MOGAD: A Shifting Landscape—From Pathogenesis to Personalised Management, Global Perspectives and Latin American Insights
| dc.catalogador | jlo | |
| dc.contributor.author | Ciampi, Ethel | |
| dc.date.accessioned | 2025-10-02T18:37:46Z | |
| dc.date.available | 2025-10-02T18:37:46Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has emerged as a distinct autoimmune demyelinating disorder, characterised by clinical, radiological, and immunopathological features that differentiate it from Multiple Sclerosis (MS) and AQP4+ neuromyelitis optica spectrum disorder (AQP4+NMOSD). This review provides a comprehensive synthesis of the evolving landscape of MOGAD, from its immunopathogenesis and diagnostic criteria to treatment strategies and global epidemiological insights. We explore the role of MOG-IgG antibodies in disease mechanisms, the utility of emerging biomarkers, and the prognostic value of tools like clinical scores or longitudinal MOG-IgG assessment. Special attention is given to regional disparities, with a focus on Latin America, highlighting diagnostic delays, access inequities, and unique clinical phenotypes. We also examine the limitations of current evidence, including gaps in long-term longitudinal follow-up and variability in diagnostic testing. Finally, we discuss global collaborative efforts and clinical trials that are shaping the future of personalised care in MOGAD. As the field advances, integrating biomarker-driven monitoring, equitable access to therapies, and regionally adapted guidelines will be essential to improving outcomes for patients worldwide. | |
| dc.format.extent | 28 páginas | |
| dc.fuente.origen | ORCID | |
| dc.identifier.doi | 10.3390/biomedicines13102344 | |
| dc.identifier.issn | 2227-9059 | |
| dc.identifier.uri | https://doi.org/10.3390/biomedicines13102344 | |
| dc.identifier.uri | https://repositorio.uc.cl/handle/11534/105884 | |
| dc.information.autoruc | Escuela de Medicina; Ciampi Díaz, Ethel Leslie; 0000-0002-7330-5433; 132794 | |
| dc.language.iso | en | |
| dc.nota.acceso | contenido completo | |
| dc.revista | Biomedicines | |
| dc.rights | acceso abierto | |
| dc.rights.license | CC BY 4.0 Attribution 4.0 International Deed | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.ddc | 610 | |
| dc.subject.dewey | Medicina y salud | es_ES |
| dc.subject.ods | 03 Good health and well-being | |
| dc.subject.odspa | 03 Salud y bienestar | |
| dc.title | MOGAD: A Shifting Landscape—From Pathogenesis to Personalised Management, Global Perspectives and Latin American Insights | |
| dc.type | artículo | |
| dc.volumen | 13 | |
| sipa.codpersvinculados | 132794 | |
| sipa.trazabilidad | ORCID;2025-09-29 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- biomedicines-13-02344.pdf
- Size:
- 2.66 MB
- Format:
- Adobe Portable Document Format
- Description:
